B
Biomea Fusion D
D
BMEA
5.81000
USD
0.24
(4.31%)
مغلق
حجم التداول
34,214
الربح لكل سهم
0
العائد الربحي
0
P/E
-2
حجم السوق
322,270,486
العنوان: Biomea Fusion
القطاع: Healthcare
الصناعة: Biotechnology
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.